Pamatolol

From WikiProjectMed
Jump to navigation Jump to search
Pamatolol
Pamatolol.svg
Names
IUPAC name
Methyl N-[2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethyl]carbamate
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C16H26N2O4/c1-12(2)18-10-14(19)11-22-15-6-4-13(5-7-15)8-9-17-16(20)21-3/h4-7,12,14,18-19H,8-11H2,1-3H3,(H,17,20)
    Key: UGENBJKPPGFFAT-UHFFFAOYSA-N
  • InChI=1/C16H26N2O4/c1-12(2)18-10-14(19)11-22-15-6-4-13(5-7-15)8-9-17-16(20)21-3/h4-7,12,14,18-19H,8-11H2,1-3H3,(H,17,20)
    Key: UGENBJKPPGFFAT-UHFFFAOYAH
  • CC(C)NCC(COC1=CC=C(C=C1)CCNC(=O)OC)O
Properties
C16H26N2O4
Molar mass 310.394 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Pamatolol is a beta adrenergic receptor antagonist.[1]

References

  1. ^ Ban, T; Sada, S; Takahashi, Y; Sada, H; Fujita, T (1985). "Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles". Naunyn-Schmiedeberg's Archives of Pharmacology. 329 (1): 77–85. doi:10.1007/bf00695196. PMID 2582279. S2CID 6067337.